缩写名/全名 |
CHINESE J CANCER RES
Chinese Journal of Cancer Research |
||||||||||
ISSN号 | 1000-9604 | ||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||
影响因子 | 2015:2.201, 2016:3, 2017:3.689, 2018:2.515, 2019:4.135, | ||||||||||
出版国家 | PEOPLES R CHINA | ||||||||||
出版周期 | Quarterly | ||||||||||
年文章数 | 82 | ||||||||||
出版年份 | 1988 | ||||||||||
是否OA | No | ||||||||||
审稿周期(仅供参考) | 平均4.5月 |
||||||||||
录用比例 | 约62.5% | ||||||||||
投稿链接 | https://mc03.manuscriptcentral.com/cjcr | ||||||||||
投稿官网 | http://cjcr.amegroups.com/ | ||||||||||
h-index | 23 | ||||||||||
CiteScore | |||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1000-9604%5BISSN%5D | ||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Incidence and mortality of primary bone cancers in China, 2014. Author: Xia L1, Zheng R2, Xu Y1, Xu X1, Zhang S2, Zeng H2, Lin L1, Chen W2. Journal: Chin J Cancer Res. 2019 Feb;31(1):135-143. doi: 10.21147/j.issn.1000-9604.2019.01.08. PubMed DOI |
2. | Incidence and mortality of thyroid cancer in China, 2008-2012. Author: Du L1, Li R1, Ge M1, Wang Y1, Li H1, Chen W2, He J2. Journal: Chin J Cancer Res. 2019 Feb;31(1):144-151. doi: 10.21147/j.issn.1000-9604.2019.01.09. PubMed DOI |
3. | Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China. Author: Shi Y1, Han Y1, Yang J1, Liu P1, He X1, Zhang C1, Zhou S1, Zhou L1, Qin Y1, Song Y2, Liu Y2, Wang S2, Jin J2, Gui L1, Sun Y1. Journal: Chin J Cancer Res. 2019 Feb;31(1):152-161. doi: 10.21147/j.issn.1000-9604.2019.01.10. PubMed DOI |
4. | Prognostic value of 18F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation. Author: Ying Z1, Mi L2, Zhou N3, Wang X3, Yang Z3, Song Y1, Wang X1, Zheng W1, Lin N1, Tu M1, Xie Y1, Ping L1, Zhang C1, Liu W1, Deng L1, Zhu J1. Journal: Chin J Cancer Res. 2019 Feb;31(1):162-170. doi: 10.21147/j.issn.1000-9604.2019.01.11. PubMed DOI |
5. | Metastatic patterns and surgical methods for lymph nodes No. 5 and No. 6 in proximal gastric cancer. Author: Wang J1, Wu P2, Wang Z2, Li K2, Huang B2, Wang P2, Xu H2, Zhu Z2. Journal: Chin J Cancer Res. 2019 Feb;31(1):171-177. doi: 10.21147/j.issn.1000-9604.2019.01.12. PubMed DOI |
6. | Risk-stratification model to select conversion surgery for advanced gastric cancer patients. Author: Nie R1, Yuan S1, Li Y1, Chen S2, Li S3, Yang L1, Yang L1, Chen Y1, Zhou Z1. Journal: Chin J Cancer Res. 2019 Feb;31(1):178-187. doi: 10.21147/j.issn.1000-9604.2019.01.13. PubMed DOI |
7. | Prognostic implications of epidermal growth factor receptor variant III expression and nuclear translocation in Chinese human gliomas. Author: Yang K1,2,3, Ren X1,2,3, Tao L4, Wang P5,6, Jiang H1,2,3, Shen L5,6, Zhao Y4, Cui Y1,2,3, Li M1,2,3, Lin S1,2,3. Journal: Chin J Cancer Res. 2019 Feb;31(1):188-202. doi: 10.21147/j.issn.1000-9604.2019.01.14. PubMed DOI |
8. | STIM1 expression is associated with osteosarcoma cell survival. Author: Zang J1,2, Zuo D1,3, Shogren KL1, Gustafson CT1, Zhou Z1, Thompson MA4, Guo R5, Prakash YS3,6, Lu L1,6, Guo W2, Maran A1,6, Yaszemski MJ1,6. Journal: Chin J Cancer Res. 2019 Feb;31(1):203-211. doi: 10.21147/j.issn.1000-9604.2019.01.15. PubMed DOI |
9. | Colorectal cancer, radiotherapy and gut microbiota. Author: Zhang S1, Wang Q1, Zhou C1, Chen K1, Chang H1, Xiao W1, Gao Y1. Journal: Chin J Cancer Res. 2019 Feb;31(1):212-222. doi: 10.21147/j.issn.1000-9604.2019.01.16. PubMed DOI |
10. | A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer. Author: Zhao J, Zhuo M, Wang Z, Duan J, Wang Y, Wang S, An T, Wu M, Wang J. Journal: Chin J Cancer Res. 2016 Feb;28(1):12-8. doi: 10.3978/j.issn.1000-9604.2016.02.07. PubMed |
|
|